Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Association between latent toxoplasmosis and clinical course of schizophrenia - continuous course of the disease is characteristic for Toxoplasma gondii-infected patients

T. Celik, S. Kartalci, O. Aytas, G. A. Akarsu, H. Gozukara, S. Unal,

. 2015 ; 62 () : 1-6.

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc15020373

The aim of the present study was to investigate the association between various clinical aspects of schizophrenia and seropositivity against Toxoplasma gondii (Nicolle et Manceaux, 1908). We selected 94 patients with schizophrenia and investigated the seropositivity rate for anti-T. gondii IgG antibodies by ELISA. Clinical parameters of schizophrenic patients such as illness type and status, clinical course, awareness of the illness and need for electroconvulsive therapy (ECT) were compared with their serological status. Anti-T. gondii IgG antibodies were detected in 43 (46%) of schizophrenic patients. Chronic patients had a rate of 34 (72%) seropositivity, whereas 9 (22%) of the patients with partial remission showed evidence of latent toxoplasmosis. Of continuous patients, 35 (81%) were found to be seropositive and this rate was significantly more than in the other groups. The rate of latent toxoplasmosis was detected significantly higher in patients who lack awareness of schizophrenia (36, i.e. 72%) than the patients who were aware of their illnesses (7, i.e. 16%). Anti-T. gondii IgG antibodies were detected in 38 (70%) of ECT performed patients while this percentage was 13% in the ones who had never been treated with ECT. This difference was also statistically significant. We showed that Toxoplasma-infected subjects had 15× higher probability of having continuous course of disease than Toxoplasma-free subjects. Our results put forth the possibility of latent toxoplasmosis to have a negative impact on the course of schizophrenia and treatment response of schizophrenic patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15020373
003      
CZ-PrNML
005      
20210529034914.0
007      
cr|cn|
008      
190227s2015 xr fs 000 0|eng||
009      
AR
024    7_
$a 10.14411/fp.2015.015 $2 doi
035    __
$a (PubMed)25960559
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Celik, Tuncay $u Department of Parasitology, Faculty of Medicine, Adiyaman University, Adiyaman, Turkey
245    10
$a Association between latent toxoplasmosis and clinical course of schizophrenia - continuous course of the disease is characteristic for Toxoplasma gondii-infected patients / $c T. Celik, S. Kartalci, O. Aytas, G. A. Akarsu, H. Gozukara, S. Unal,
520    3_
$a The aim of the present study was to investigate the association between various clinical aspects of schizophrenia and seropositivity against Toxoplasma gondii (Nicolle et Manceaux, 1908). We selected 94 patients with schizophrenia and investigated the seropositivity rate for anti-T. gondii IgG antibodies by ELISA. Clinical parameters of schizophrenic patients such as illness type and status, clinical course, awareness of the illness and need for electroconvulsive therapy (ECT) were compared with their serological status. Anti-T. gondii IgG antibodies were detected in 43 (46%) of schizophrenic patients. Chronic patients had a rate of 34 (72%) seropositivity, whereas 9 (22%) of the patients with partial remission showed evidence of latent toxoplasmosis. Of continuous patients, 35 (81%) were found to be seropositive and this rate was significantly more than in the other groups. The rate of latent toxoplasmosis was detected significantly higher in patients who lack awareness of schizophrenia (36, i.e. 72%) than the patients who were aware of their illnesses (7, i.e. 16%). Anti-T. gondii IgG antibodies were detected in 38 (70%) of ECT performed patients while this percentage was 13% in the ones who had never been treated with ECT. This difference was also statistically significant. We showed that Toxoplasma-infected subjects had 15× higher probability of having continuous course of disease than Toxoplasma-free subjects. Our results put forth the possibility of latent toxoplasmosis to have a negative impact on the course of schizophrenia and treatment response of schizophrenic patients.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a toxoplazmóza $x etiologie $x imunologie $x komplikace $7 D014123
650    _2
$a latentní infekce $x etiologie $x imunologie $x komplikace $7 D000085343
650    12
$a schizofrenie $x imunologie $x klasifikace $x krev $x patofyziologie $7 D012559
650    _2
$a Toxoplasma $x imunologie $x patogenita $7 D014122
650    _2
$a prognóza $7 D011379
650    _2
$a statistika jako téma $7 D013223
653    00
$a séropozitivita
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kartalci, Sukru $u Department of Psychiatry, Faculty of Medicine, Inonu University, Malatya, Turkey
700    1_
$a Aytas, Ozgur $u Malatya State Hospital, Department of Psychiatry, Malatya, Turkey $7 gn_A_00010617
700    1_
$a Akarsu, Gulay Aral $u Department of Parasitology, Faculty of Medicine, Ankara University, Ankara, Turkey $7 gn_A_00002825
700    1_
$a Gozukara, Harika $u Department of Biostatistics, Inonu University, Malatya, Turkey
700    1_
$a Unal, Suheyla $u Department of Psychiatry, Faculty of Medicine, Inonu University, Malatya, Turkey
773    0_
$w MED00011006 $t Folia parasitologica $x 0015-5683 $g Roč. 62(2015), s. 1-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25960559 $y Pubmed
856    41
$u https://folia.paru.cas.cz/pdfs/fol/2015/01/15.pdf $y plný text volně přístupný
910    __
$a ABA008 $b online $y a $z 0
990    __
$a 20150616 $b ABA008
991    __
$a 20210529034915 $b ABA008
999    __
$a ok $b bmc $g 1080714 $s 903335
BAS    __
$a 3 $a 4
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 62 $d 1-6 $i 0015-5683 $m Folia parasitologica $n Folia parasitol. $x MED00011006
LZP    __
$c NLK189 $d 20210529 $b NLK118 $a Pubmed-20150616

Find record

Citation metrics

Archiving options